セルバンキングアウトソーシング市場規模、シェア、成長分析：タイプ別、製品別、細胞の種類別、フェーズ別、地域別 - 産業予測 2025～2032年

セルバンキングアウトソーシングの世界市場規模は2023年に133億米ドルと評価され、2024年の155億9,000万米ドルから2032年には554億9,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは17.2％で成長する見通しです。

世界のセルバンキングアウトソーシング市場は、凍結保存と細胞バンク調製技術の進歩に後押しされ、大幅な成長が見込まれています。モノクローナル抗体や効果的なバイオ医薬品に対する需要の高まりと並んで、幹細胞治療の普及がこの分野をさらに後押ししています。2020年初頭には、先進的な細胞治療の臨床試験が世界的に30%急増するという注目すべき数字が、細胞バンクサービスのニーズの高まりを裏付けています。政府の支援策や細胞株保存・特性解析の革新的技術が市場拡大に弾みをつけています。Opsis Therapeutics社やFUJIFILM Cellular Dynamics社など、主要な業界企業間の共同研究が研究開発努力を後押ししており、その例として、健康状態の改善におけるヒト誘導多能性幹細胞の有効性を示す研究が挙げられます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

セルバンキングアウトソーシング市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• マスターセルバンキング
• ウイルスセルバンキング
• ワーキングセルバンキング

セルバンキングアウトソーシング市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 臍帯細胞バンキング
• 成人幹細胞バンキング
• 人工多能性幹細胞バンキング
• 胚性幹細胞バンキング

セルバンキングアウトソーシング市場規模：細胞の種類別& CAGR（2025-2032）

• 市場概要
• 幹細胞
  • 臍帯細胞バンキング
  • 胚性幹細胞バンキング
  • 成人幹細胞バンキング
  • 歯科幹細胞バンキング
  • IPS幹細胞バンキング
• 非幹細胞

セルバンキングアウトソーシング市場規模：フェーズ別& CAGR（2025-2032）

• 市場概要
• バンク保管
  • マスターセルバンクストレージ
  • ワーキングセルバンクストレージ
  • 細胞保存安定性試験
• 細胞保存安定性試験
• バンクの準備
  • マスターセルバンクの準備
  • ワーキングセルバンクの準備
• バンクの特性評価とテスト
  • 安全性試験
  • ウイルス細胞バンク
  • 微生物細胞バンク
  • 遺伝子発現検査
  • 核医学検査
  • 遺伝子配列検査

セルバンキングアウトソーシング市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Charles River Laboratories（USA）
• Lonza（Switzerland）
• Merck KGaA（Germany）
• SGS Societe Generale de Surveillance SA（Switzerland）
• Cryo-Cell International, Inc.（USA）
• LifeCell（India）
• WuXi AppTec（China）
• Eurofins Scientific（Luxembourg）
• Sartorius（Bio Outsource）（Germany）
• BSL Bioservice（Germany）
• Key Developments
• ViaCord（USA）
• StemCyte, Inc.（USA）
• Cryoviva Biotech Pvt. Ltd.（India）

結論と提言

Global Cell Banking Outsourcing Market size was valued at USD 13.3 billion in 2023 and is poised to grow from USD 15.59 billion in 2024 to USD 55.49 billion by 2032, growing at a CAGR of 17.2% during the forecast period (2025-2032).

The global cell banking outsourcing market is poised for substantial growth, fueled by advancements in cryopreservation and cell bank preparation techniques. The increasing prevalence of stem cell therapies, alongside a rising demand for monoclonal antibodies and effective biopharmaceuticals, is further propelling this sector. A notable 30% surge in global enrollments for advanced cell therapy trials in early 2020 underscores the escalating need for cell banking services. Supportive government initiatives and innovative technologies for cell line storage and characterization add momentum to market expansion. Collaborations among key industry players, such as Opsis Therapeutics and FUJIFILM Cellular Dynamics, bolster research and development efforts, exemplified by studies indicating the efficacy of human-induced pluripotent stem cells in enhancing health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Banking Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Banking Outsourcing Market Segments Analysis

Global Cell Banking Outsourcing Market is segmented by Type, Product, Cell Type, Phase and region. Based on Type, the market is segmented into Master Cell Banking, Viral Cell Banking and Working Cell Banking. Based on Product, the market is segmented into Cord Cell Banking, Adult Stem Cell Banking, Induced Pluripotent Stem Cell Banking and Embryonic Stem Cell Banking. Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell. Based on Phase, the market is segmented into Bank Storage, Cell Storage Stability Testing, Bank Preparation and Bank Characterization and Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Banking Outsourcing Market

A key factor propelling the global cell banking outsourcing market is the rising adoption of stem cell therapies, which is a burgeoning area within regenerative medicine known for its potential to address a variety of medical conditions. As the appetite for such therapies intensifies, the requirement for stable, high-quality cell lines becomes more pronounced, thereby boosting the demand for specialized cell banking services. Consequently, biopharmaceutical companies and contract research organizations (CROs) are increasingly turning to outsourcing for effective and economical solutions related to the production and preservation of these essential cell lines, ultimately driving market growth in this sector.

Restraints in the Global Cell Banking Outsourcing Market

A significant constraint on the global cell banking outsourcing market is the elevated cost associated with cell banking services. The cell banking process entails thorough testing and characterization to guarantee the quality and safety of cell lines, necessitating substantial investments in specialized equipment and infrastructure, which contributes to heightened service costs. Additionally, strict regulations enforced by regulatory authorities regarding the production and storage of cell lines further exacerbate expenses. Consequently, the high costs of these services may hinder their adoption, particularly in developing regions where healthcare budgets are constrained, creating a barrier to accessing essential cell banking solutions.

Market Trends of the Global Cell Banking Outsourcing Market

The Global Cell Banking Outsourcing market is currently witnessing a significant trend driven by the rising demand for personalized medicine which necessitates the use of genetically tailored cells for effective treatments. As healthcare evolves towards individualized approaches, cell banking firms are increasingly investing in advanced technologies and innovations to produce and store these specific cell types. This trend not only enhances treatment efficacy by aligning therapies with patients' unique genetic profiles but also propels market growth as more healthcare providers seek outsourcing solutions to streamline operations and improve patient outcomes. Consequently, the intersection of personalized medicine and cell banking is poised to reshape market dynamics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Banking Outsourcing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Master Cell Banking
• Viral Cell Banking
• Working Cell Banking

Global Cell Banking Outsourcing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cord Cell Banking
• Adult Stem Cell Banking
• Induced Pluripotent Stem Cell Banking
• Embryonic Stem Cell Banking

Global Cell Banking Outsourcing Market Size by Cell Type & CAGR (2025-2032)

• Market Overview
• Stem Cell
  • Cord Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
• Non-Stem Cell

Global Cell Banking Outsourcing Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing
• Cell Storage Stability Testing
• Bank Preparation
  • Master Cell Bank Preparation
  • Working Cell Bank Preparation
• Bank Characterization and Testing
  • Safety Testing
  • Viral Cell Banks
  • Microbial Cell Banks
  • Gene Expression Testing
  • Karyology Testing
  • Gene Sequencing Testing

Global Cell Banking Outsourcing Market Size & CAGR (2025-2032)

• North America (Type, Product, Cell Type, Phase)
  • US
  • Canada
• Europe (Type, Product, Cell Type, Phase)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Cell Type, Phase)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Cell Type, Phase)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Cell Type, Phase)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS Societe Generale de Surveillance SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius (Bio Outsource) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BSL Bioservice (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• ViaCord (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoviva Biotech Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations